This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Data availability
Data are available from the corresponding author upon reasonable request.
References
Ciurea SO, Zhang MJ, Bacigalupo AA, Bashey A, Appelbaum FR, Aljitawi OS, et al. Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia. Blood. 2015;126:1033–40. https://doi.org/10.1182/blood-2015-04-639831.
Saglio F, Berger M, Spadea M, Pessolano R, Carraro F, Barone M, et al. Haploidentical HSCT with post transplantation cyclophosphamide versus unrelated donor HSCT in pediatric patients affected by acute leukemia. Bone Marrow Transpl. 2021;56:586–95. https://doi.org/10.1038/s41409-020-01063-2.
Fierro-Pineda JC, Tsai HL, Blackford A, Cluster A, Caywood E, Dalal J, et al. Prospective PTCTC trial of myeloablative haplo-BMT with posttransplant cyclophosphamide for pediatric acute leukemias. Blood Adv. 2023;7:5639–48. https://doi.org/10.1182/bloodadvances.2023010281.
Pochon C, Detrait M, Dalle JH, Michel G, Dhédin N, Chalandon Y, et al. Improved outcome in children compared to adolescents and young adults after allogeneic hematopoietic stem cell transplant for acute myeloid leukemia: a retrospective study from the Francophone Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC). J Cancer Res Clin Oncol. 2022;148:2083–97. https://doi.org/10.1007/s00432-021-03761-w.
Penack O, Marchetti M, Aljurf M, Arat M, Bonifazi F, Duarte RF, et al. Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation. Lancet Haematol. 2024;11:e147–59. https://doi.org/10.1016/S2352-3026(23)00342-3.
Tiercy JM. How to select the best available related or unrelated donor of hematopoietic stem cells?. Haematologica. 2016;101:680–7. https://doi.org/10.3324/haematol.2015.141119.
Ruggeri A, Santoro N, Galimard JE, Kalwak K, Algeri M, Zubarovskaya L, et al. Matched unrelated donor transplantation versus haploidentical transplantation with post-transplant cyclophosphamide in children with acute myeloid leukemia: a PDWP-EBMT study. Haematologica. 2024;109:2122–30. https://doi.org/10.3324/haematol.2023.284445.
Srinivasan A, Raffa E, Wall DA, Schechter T, Ali M, Chopra Y, et al. Outcome of Haploidentical Peripheral Blood Allografts Using Post-Transplantation Cyclophosphamide Compared to Matched Sibling and Unrelated Donor Bone Marrow Allografts in Pediatric Patients with Hematologic Malignancies: A Single-Center Analysis. Transpl Cell Ther. 2022;28:158.e1–158.e9. https://doi.org/10.1016/j.jtct.2021.11.009.
Nagler A, Labopin M, Blaise D, Raiola AM, Corral LL, Bramanti S, et al. Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT. J Hematol Oncol. 2023;16:58. https://doi.org/10.1186/s13045-023-01450-4.
Seber A, Arcuri LJ, Colturato VR, Souza MP, Zogbi YAN, Funke V, et al. Haploidentical, matched-related, and matched-unrelated hematopoietic cell transplant for acute leukemias in the early years of haploidentical transplant implementation in a developing country with a large unrelated donor registry. Front Oncol. 2025;15:1584631. https://doi.org/10.3389/fonc.2025.1584631.
Bacigalupo A, Lamparelli T, Barisione G, Bruzzi P, Guidi S, Alessandrino PE, et al. Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation. Biol Blood Marrow Transpl. 2006;12:560–5. https://doi.org/10.1016/j.bbmt.2005.12.034.
Walker I, Panzarella T, Couban S, Couture F, Devins G, Elemary M, et al. Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial. Lancet Haematol. 2020;7:e100–11. https://doi.org/10.1016/S2352-3026(19)30220-0.
Acknowledgements
The authors thank all the investigators of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). The work of all clinical research assistants is also acknowledged.
Author information
Authors and Affiliations
Contributions
A-M.F. and N.R. assembled the data; A-M.F. and L.V. analyzed the data and performed the statistical analyses; J.L. supervised the statistical analyses; A.-M.F., N.D., and L.V. drafted the manuscript; N.D. and S.N. supervised the study; A.-M.F, D.B., M.B., J.M., E.F., A.H., X.P., R.D., C.C-L., P.C., C.P., E.D., P.L., C-E.B., and E.B., S.N. provided clinical data; all authors revised the manuscript and accepted the final version.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval statement
The study is registered in the French Health Data Hub (www.health-data-hub.fr, F20230125121102).
Patient consent statement
Patients or their guardians provided written informed consent for data analysis.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Fourmont, AM., Beauvais, D., Balsat, M. et al. Alternative versus matched unrelated donor in adolescents and young adults transplanted for acute myeloid leukemia in first complete remission: A report from the SFGM-TC. Bone Marrow Transplant (2026). https://doi.org/10.1038/s41409-026-02853-w
Received:
Revised:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41409-026-02853-w